Worsening of obsessive-compulsive symptoms after treatment with aripiprazole [19]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 2, 2007, Pages 237-238

  Mouaffak, Fayçal ^a   Gallarda, Thierry ^a   Baylé, Franck Jean ^a   Olié, Jean Pierre ^a   Baup, Nicolas ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; CYAMEMAZINE; RISPERIDONE;

ADULT; ANXIETY DISORDER; CASE REPORT; COMORBIDITY; COMPULSION; CONTAMINATION; DELUSION; DISEASE EXACERBATION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EATING DISORDER; FEMALE; HAND WASHING; HUMAN; INFESTATION; LETTER; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SLEEP DISORDER; THERAPY RESISTANCE; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; QUINOLONES; TREATMENT OUTCOME;

EID: 34247153071     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000264981.94614.54     Document Type: Letter

References (6)

1. Taylor DM. Aripiprazole: a review of its pharmacology and clinical use. Int J Clin Pract. 2003;57:49-54.
2. Lykouras L, Alevizos B, Michalopoulou P. Obsessive compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:333-346.
3. Poyurovsky M, Weizman A, Weizman R. Obsessive-compusive disorder in schizophrenia. Clinical characteristics and treatment. CNS Drugs. 2004;18:989-1010.
4. Poyurovsky M, Bergman Y, Shoshani D, et al. Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol. 1998;21:97-100.
5. MacCabe JH, Travis M. Clozapine-induced obsessive-compulsive symptoms. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1209.
6. Tamminga CA. Partial dopamine agonists in the treatment of psychosis. J Neural Transm. 2002;109:411-422.